With the dramatic increase in life expectancy in recent years, Israeli biotech firm Cellect, a world leader in stem cell research, discusses the latest technology, giving hope to the elderly population to maintain a decent quality of life. “If we plan to live longer lives, we need to move away from the concept of fixing to replacing,” the company says, also explaining how it has eliminated the challenges over the abortion controversy in stem cell research.





